[ Price : $8.95]
Three Akin attorneys say regulated industry continues to have questions about FDA actions in launching an internal artificial inte...[ Price : $8.95]
FDAs Oncologic Drugs Advisory Committee votes against approving GSKs BLA for Blenrep (belantamab mafodotin) for treating adults wi...[ Price : $8.95]
Dexcom recalls certain Dexcom G6, G7, ONE, and ONE+ glucose monitoring receivers because a speaker problem may prevent an alert fr...[ Price : $8.95]
Sen. Marsha Blackburn and Tennessee attorney general Jonathan Skrmetti call on the Federal Trade Commission to open an investigati...[ Price : $8.95]
FDA warns Boston, MA-based Whoop that it is illegally marketing an unapproved medical device that estimates blood pressure, despit...[ Price : $8.95]
A Phase 3 clinical trial evaluating Alexions anselamimab for light chain amyloidosis fails to meet its primary endpoint, but shows...[ Price : $8.95]
FDA releases a funding opportunity for natural history studies to advance product development in rare diseases and conditions.[ Price : $8.95]
FDA releases the form FDA-483 with seven observations from an inspection at Indias Natco Pharma.